News & Articles

The partnership aims to co-market exosome technology as well as the joint development of new exosome based products

The collaboration aims to define threshold for neutralizing antibody sufficient to confer immunity

Access Anti-SARS-CoV-2 Antigen Test, developed in collaboration with Ellume, aims to provide accurate results in less than 15 minutes

Agreements with AstraZeneca and the University of Nebraska Medical Center showcase new workflows to improve the throughput, robustness and standardization of clinical biomarker analysis

RiboShield RNase Inhibitor complements PCR Biosystems’s range of products to support COVID-19 research and testing

The agreement is part of preparations for GMP production of material for the first clinical study of CG01

Watch this on-demand webinar to discover the critical factors when choosing an assay for coronavirus testing

Join us on Monday, September 21, to learn about assay development for high-throughput screening

New research published in Nature Immunology show strong T cell responses in patients recovered from COVID-19

CDx approval expands clinical utility of Oncomine Dx Target Test to identify candidates for GAVRETO

New test expands Roche molecular test menu for transplant patients, enabling simultaneous testing of BK virus with Cytomegalovirus and Epstein-Barr virus

Test to be integrated in over 5,000 DiaSorin analyzers, allowing physicians to differentiate between bacterial and viral infections

Sanofi and GSK are scaling up the manufacturing of the antigen and adjuvant with the target of producing up to one billion doses in 2021

Data shows 100% concordance with results from Dartmouth-Hitchcock’s lab-based polymerase chain reaction (PCR) test method

Rapid increase in production of VTM and saline will help boost virus testing

Watch this on-demand webinar to learn about the latest approaches in single nucleus transcriptomics and ATAC-Seq

The new AI technology will learn from past CT scans of COVID-19 pneumonia patients, reducing the burden on doctors making diagnoses

Ready-to-use kit enables rapid adeno-associated virus (AAV) titer determinations during the manufacture of AAV vectors

Antigen test reliably and quickly triages people suspected of SARS-CoV-2, with results ready in 15 minutes, allowing informed treatment decisions

Combining image analysis with structured reporting, the software aims to improve and accelerate the detection of the virus

Test delivers results in just 15 minutes with no instrumentation, using proven lateral flow technology with demonstrated sensitivity of 97.1% and specificity of 98.5%

The real-time PCR workflow has a capacity of up to 6,000 tests per day per system, and demonstrated 100% agreement with authorized nasopharyngeal assays

QIAseq SARS-CoV-2 Primer Panel converts viral RNA samples into libraries ready for sequencing, whereas QIAGEN Digital Insights solutions support COVID-19 drug, vaccine and epidemiology research

Syndromic testing will streamline respiratory infection diagnosis as COVID-19 pandemic collides with start of flu season